Fresenius Kabi Takes On Drug Shortages With Iodixanol Launch
German Firm Has Also Launched First Generic Romidepsin Rival To Istodax
Executive Summary
Fresenius Kabi has launched a generic iodixanol injection in the US, at a time when the drug is subject to a nationwide shortage. At the same time, the firm has introduced the country’s first Istodax rival.
You may also be interested in...
Increased Transparency Key To Combating Drug Shortages, Says US Industry Alliance
The closure of a Teva manufacturing plant in California has raised concerns around access a number of medicines, something the End Drug Shortages Alliance says could be avoided through increased market transparency.
Fresenius Kabi Introduces Cancer Copay Scheme For Generics
German pharma giant Fresenius Kabi has introduced a copay scheme for a number of its generic oncology medicines in the US, which could completely eliminate monthly costs for certain patients.
Numerous US Approvals Received By Lupin Following 278% Quarterly Profits Raise
Lupin has announced a number of drug approvals in the US, as well as a biosimilar partnership in the Middle East and the launch of a novel fixed-dose triple combination drug in its native Indian market.